Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy.

In this study, while mean CSF NSE levels were higher in PD group than in CSM and control groups and lower in PD groups than in ALS group, these differences did not reach statistical significance.

also in 111,027 other papers